130
Participants
Start Date
November 27, 2023
Primary Completion Date
March 31, 2027
Study Completion Date
March 31, 2027
GSK3862995B
GSK3862995B will be administered.
Placebo
Placebo will be administered.
RECRUITING
GSK Investigational Site, Berlin
RECRUITING
GSK Investigational Site, Berlin
RECRUITING
GSK Investigational Site, Berlin
RECRUITING
GSK Investigational Site, Schwerin
RECRUITING
GSK Investigational Site, Hamburg
RECRUITING
GSK Investigational Site, Ahrensburg
RECRUITING
GSK Investigational Site, Lübeck
RECRUITING
GSK Investigational Site, Shelby
RECRUITING
GSK Investigational Site, Wilmington
RECRUITING
GSK Investigational Site, Rock Hill
RECRUITING
GSK Investigational Site, Hanover
RECRUITING
GSK Investigational Site, Columbus
RECRUITING
GSK Investigational Site, Hialeah
RECRUITING
GSK Investigational Site, Plantation
RECRUITING
GSK Investigational Site, Immenhausen
RECRUITING
GSK Investigational Site, Mainz
RECRUITING
GSK Investigational Site, Frankfurt
RECRUITING
GSK Investigational Site, Austin
RECRUITING
GSK Investigational Site, München
RECRUITING
GSK Investigational Site, Yuma
RECRUITING
GSK Investigational Site, Medford
RECRUITING
GSK Investigational Site, Dresden
RECRUITING
GSK Investigational Site, Hamburg
RECRUITING
GSK Investigational Site, Leipzig
RECRUITING
GSK Investigational Site, Barnsley
RECRUITING
GSK Investigational Site, Blackpool
RECRUITING
GSK Investigational Site, Cambridge
RECRUITING
GSK Investigational Site, Cannock
RECRUITING
GSK Investigational Site, London
RECRUITING
GSK Investigational Site, London
RECRUITING
GSK Investigational Site, Manchester
RECRUITING
GSK Investigational Site, West Yorkshire
Lead Sponsor
GlaxoSmithKline
INDUSTRY